Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

924
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
924
Tumor Immunotherapy01:27

Tumor Immunotherapy

530
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
530
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

747
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
747
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

68.4K
Overview
68.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Melatonin and glaucoma: Current insights and clinical prospectives.

Archivos de la Sociedad Espanola de Oftalmologia·2026
Same author

The Importance of Early Mycological Clearance of Uncomplicated Candidaemia and Its Implications for Clinical Practice.

Mycoses·2025
Same author

Gel nail polish does not have a negative impact on the nail bacterial burden nor on the quality of hand hygiene with an alcohol-based hand rub.

The Journal of hospital infection·2024
Same author

Strengths and weaknesses of computerized clinical decision support systems: insights from a digital control center (C3 COVID-19) for early and personalized treatment for COVID-19.

Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia·2024
Same author

MKRN3 circulating levels in girls with central precocious puberty caused by MKRN3 gene mutations.

Journal of endocrinological investigation·2023
Same author

Bioelectrical impedance analysis in patients with posterior vitreous detachment.

European review for medical and pharmacological sciences·2023

Related Experiment Video

Updated: Jul 10, 2025

Transduction and Expansion of Primary T Cells in Nine Days with Maintenance of Central Memory Phenotype
08:49

Transduction and Expansion of Primary T Cells in Nine Days with Maintenance of Central Memory Phenotype

Published on: March 18, 2020

11.1K

Post-CART-T Cell Infection: Etiology, pathogenesis, and therapeutic approaches.

N García-Poutón, O Peyrony, M Chumbita

  • 1Carolina Garcia-Vidal, Infectious Diseases Department, Hospital Clínic-IDIBAPS, Barcelona, Spain. Carrer de Villarroel 170, 08036, Barcelona, Spain. cgarciav@clinic.cat and carolgv75@hotmail.com.

Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia
|November 24, 2023
PubMed
Summary
This summary is machine-generated.

CAR T-cell therapy for B-cell cancers increases infection risk. This review details infections, risk factors, and prevention strategies like vaccination and antibiotics to improve patient outcomes.

More Related Videos

Automated Cell Enrichment of Cytomegalovirus-specific T cells for Clinical Applications using the Cytokine-capture System
10:24

Automated Cell Enrichment of Cytomegalovirus-specific T cells for Clinical Applications using the Cytokine-capture System

Published on: October 5, 2015

12.5K
Immunometabolic Circuits in Infection for Advancing Host Directed Therapies
11:12

Immunometabolic Circuits in Infection for Advancing Host Directed Therapies

Published on: September 13, 2024

433

Related Experiment Videos

Last Updated: Jul 10, 2025

Transduction and Expansion of Primary T Cells in Nine Days with Maintenance of Central Memory Phenotype
08:49

Transduction and Expansion of Primary T Cells in Nine Days with Maintenance of Central Memory Phenotype

Published on: March 18, 2020

11.1K
Automated Cell Enrichment of Cytomegalovirus-specific T cells for Clinical Applications using the Cytokine-capture System
10:24

Automated Cell Enrichment of Cytomegalovirus-specific T cells for Clinical Applications using the Cytokine-capture System

Published on: October 5, 2015

12.5K
Immunometabolic Circuits in Infection for Advancing Host Directed Therapies
11:12

Immunometabolic Circuits in Infection for Advancing Host Directed Therapies

Published on: September 13, 2024

433

Area of Science:

  • Immunology
  • Oncology
  • Infectious Diseases

Background:

  • Chimeric antigen receptor (CAR) T-cell therapy targeting CD19 is a breakthrough for refractory B-cell malignancies.
  • This therapy can lead to significant immune compromise, increasing infection susceptibility.

Purpose of the Study:

  • To review the spectrum of infections in CAR T-cell therapy recipients.
  • To identify key risk factors for infection.
  • To outline essential infection prevention and management strategies.

Main Methods:

  • Literature review of infections associated with CAR T-cell therapy.
  • Analysis of risk factors including corticosteroid use, hypogammaglobulinemia, and cytokine release syndrome (CRS).

Main Results:

  • Patients are at risk for bacterial, viral, and fungal infections.
  • Severe CRS, corticosteroid use, and low immunoglobulin levels are significant risk factors.
  • Infections pose a major threat to patient outcomes.

Conclusions:

  • Prophylactic measures, including vaccination and immunoglobulin replacement, are crucial.
  • Clear guidelines for antibiotic use and vaccinating close contacts are recommended.
  • Optimizing infection prevention is essential for successful CAR T-cell therapy outcomes.